Related Experiment Video
Updated: Jun 20, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease
P D'Amelio1, G Isaia, G C Isaia
1Department of Surgical and Medical Disciplines, University of Turin, Turin, Italy. patrizia.damelio@unito.it
Insights
Osteoporosis and cardiovascular disease share links beyond aging, potentially mediated by the osteoprotegerin (OPG)/RANK/RANKL system. This system
Area of Science:
- Biomedical Science
- Gerontology
- Cardiovascular Research
Background:
- Osteoporosis and atherosclerosis are common age-related degenerative diseases.
- Recent research suggests a link between osteoporosis and cardiovascular diseases beyond aging.
- The osteoprotegerin (OPG)/receptor activator of nuclear factor-kB (RANK)/RANK ligand (RANKL) system is implicated in arterial calcification.
Purpose of the Study:
- To review recent findings on the relationship between osteoporosis and OPG/RANK/RANKL-mediated vascular disease.
- To explore the role of the OPG/RANK/RANKL system in vascular biology.
- To discuss the potential of OPG as a marker for vascular disease.
Main Methods:
- Literature review of recent studies.
- Analysis of research on the OPG/RANK/RANKL system in skeletal and vascular biology.
- Synthesis of findings on the association between osteoporosis and vascular calcification.
Main Results:
- The OPG/RANK/RANKL system is a potential mediator linking osteoporosis and vascular diseases.
- OPG may function as an autocrine/paracrine regulator of vascular calcification.
- The precise role of OPG/RANKL/RANK in vascular calcification requires further investigation.
Conclusions:
- The OPG/RANK/RANKL system offers a potential common pathway for osteoporosis and vascular diseases.
- Further research is needed to fully elucidate the role of this system in vascular calcification.
- OPG may serve as a valuable serum marker for vascular disease detection.
Abstract:
Osteoporosis and atherosclerosis are degenerative disorders of old age that often present together, but recently it has been suggested that the association between osteoporosis and cardio-vascular diseases is not just due to the aging process. The osteoprotegerin (OPG)/receptor activator of nuclear factor-kB (RANK)/RANK ligand (RANKL) system has been identified as a possible mediator of arterial calcification suggesting common links between osteoporosis and vascular diseases. Since the discovery of the OPG/RANK/RANKL system, much has been learned about its role in controlling skeletal biology; however, its role in the context of vascular biology is only beginning to be explored. It has been suggested that OPG might act as an autocrine/paracrine regulator of vascular calcification and might be useful as a serum marker of vascular disease. However, the exact role of OPG (or RANKL/RANK) in vascular calcification is still not completely understood. This review aims to report the recent findings on the relationship between osteoporosis and OPG/RANK/RANKL-mediated vascular disease.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
What is the Skeletal System?
Regulation of Angiogenesis and Blood Supply
